Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis

被引:56
|
作者
Qi, Jing
Liu, Ning
Zhou, Yuan
Tan, Yaohong
Cheng, Yanhong
Yang, Chunzheng
Zhu, Zhenping [1 ]
Xiong, Dongsheng
机构
[1] Peking Union Med Coll, Inst Hematol, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China
[2] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin 300020, Peoples R China
[3] Chinese Acad Sci, Changchun Inst Appl Chem, Lab New Drug Res & Mass Spectrometry, Changchun 130022, Peoples R China
[4] Jilin Univ, Inst Life Sci, Changchun 130023, Peoples R China
基金
中国国家自然科学基金;
关键词
multidrug resistance; sorcin; Bcl2/Bax; apoptosis; proteomics; 2D gel analysis;
D O I
10.1016/j.bbrc.2006.08.042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In an attempt to identify novel proteins involved in the emergence of multidrug resistance (MDR) in leukemia cells, we adopted a proteomics approach to analyze protein expression patterns in leukemia cell lines, K562, and its MDR counterpart, K562/A02. Combining high resolution two-dimensional gel electrophoresis and mass spectrometry, we compared the protein expression profiles between K562 and K562/A02. A total number of 22 protein spots with altered abundances of more than 2-fold were detected and 14 proteins were successfully identified. Consistent with our previous observations by cDNA microarray, sorcin, a 22-kDa calcium-binding protein, was also identified by this proteomic approach with a 10.4-fold up-regulation in K562/A02 cells. Overexpression of sorcin protein in K562 cells by gene transfection led to significantly reduced cytosolic calcium level and increased resistance to cell apoptosis. Further, leukemia cell lines over-expressing sorcin also showed up-regulation of Bcl-2, along with decreased level of Bax. Taken together, our results suggest that sorcin plays an important role in the emergence of MDR in leukemia cells via regulating cell apoptosis pathways, thus may represent both a new MDR marker for prognosis and a good target for anti-MDR drugs development. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:303 / 309
页数:7
相关论文
共 50 条
  • [1] Overexpression of sorcin in multidrug-resistant human breast cancer
    Gong, Zhaohua
    Sun, Ping
    Chu, Hongjin
    Zhu, Hua
    Sun, Dengjun
    Chen, Jian
    ONCOLOGY LETTERS, 2014, 8 (06) : 2393 - 2398
  • [2] Overexpression of sorcin gene induces a low level of multidrug-resistance in human leukemia cells
    Xu, Yuanfu
    Zhou, Yuan
    Xiong, Dongsheng
    Qi, Jing
    Yang, Chunzheng
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 258 - 258
  • [3] Sorcin, an important gene associated with multidrug-resistance in human leukemia cells
    Zhou, Y
    Xu, YF
    Tan, YH
    Qi, J
    Xiao, Y
    Yang, CZ
    Zhu, ZP
    Xiong, DS
    LEUKEMIA RESEARCH, 2006, 30 (04) : 469 - 476
  • [4] Altered expression of the genes regulating apoptosis in multidrug resistant human myeloid leukemia cell lines overexpressing MDR1 or MRP gene
    Kim, CH
    Gollapudi, S
    Lee, T
    Gupta, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 11 (05) : 945 - 950
  • [5] POSSIBLE ROLE FOR SORCIN, A CALCIUM-BINDING PROTEIN OVERPRODUCED IN MULTIDRUG-RESISTANT (MDR) CELLS
    MEYERS, MB
    BIEDLER, JL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 290 - 290
  • [6] Overexpression of a 40-kDa protein in human multidrug resistant cells
    Wang, Y
    Pan, XQ
    Lheureux, F
    Georges, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) : 483 - 488
  • [7] ROLE OF GLUTATHIONE AND ITS ASSOCIATED ENZYMES IN MULTIDRUG-RESISTANT HUMAN MYELOMA CELLS
    BELLAMY, WT
    DALTON, WS
    MELTZER, P
    DORR, RT
    BIOCHEMICAL PHARMACOLOGY, 1989, 38 (05) : 787 - 793
  • [8] The activity of Selol in multidrug-resistant and sensitive human leukemia cells
    Suchocki, Piotr
    Misiewicz, Irena
    Skupinska, Katarzyna
    Waclawek, Karolina
    FijaleK', Zbigniew
    Kasprzycka-Guttman, Teresa
    ONCOLOGY REPORTS, 2007, 18 (04) : 893 - 899
  • [9] Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp
    Dabaghi, Mohammad
    Rahgozar, Soheila
    Moshtaghian, Jamal
    Moafi, Alireza
    Abedi, Marjan
    Pourabutaleb, Elnaz
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2016, 20 (09) : 516 - 521
  • [10] Anti-MDR Effects of Quercetin and its Nanoemulsion in Multidrug-Resistant Human Leukemia Cells
    Marques, B. Maiara
    Machado, P. Ayane
    Santos, A. Priscila
    Carrett-Dias, Michele
    Araujo, S. Gabriela
    da Silva Alves, Barbara
    de Oliveira, Barbara Santos
    da Silva Junior, M. R. Flavio
    Dora, L. Cristiana
    Canedo, D. Andres
    Filgueira, M. V. B. Daza
    Fernandes e Silva, Estela
    de Souza Votto, Ana Paula
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (14) : 1911 - 1920